ouabain has been researched along with Disease Models, Animal in 195 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 39 (20.00) | 18.7374 |
| 1990's | 24 (12.31) | 18.2507 |
| 2000's | 43 (22.05) | 29.6817 |
| 2010's | 73 (37.44) | 24.3611 |
| 2020's | 16 (8.21) | 2.80 |
| Authors | Studies |
|---|---|
| Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Botelho, AFM; Canta, GN; da Cruz, JPO; da Silva Ferreira, R; Fernandes, PBU; Lempek, MR; Mantovani, MM; Melo, MM; Silva, FLA; Veado, JCC | 1 |
| Hoai Nguyen, BC; Jeong, JH; Kim, DJ; Kim, HC; Lichtstein, D; Nabeshima, T; Nah, SY; Nguyen, BT; Sharma, N; Shin, EJ; Tran, NKC | 1 |
| Aguiar-Geraldo, JM; Cararo, JH; Dal-Pont, GC; Ferreira, CL; Marino, CAP; Possamai-Della, T; Quevedo, J; Valvassori, SS | 1 |
| Chomczynski, PW; Heiny, JA; Rymaszewski, M; Vires, KM | 1 |
| Alves, AF; Carvalho, DCM; Cavalcante-Silva, LHA; de Almeida Lima, É; Galvão, JGFM; Mascarenhas, SR | 1 |
| Aguiar-Geraldo, JM; Cararo, JH; da-Rosa, DD; Peper-Nascimento, J; Possamai-Della, T; Quevedo, J; Valvassori, SS | 1 |
| Aguiar-Geraldo, JM; Menegas, S; Peper-Nascimento, J; Possamai-Della, T; Quevedo, J; Valvassori, SS | 1 |
| Blanco, G; McDermott, JP; Sanchez, G; Trant, J | 1 |
| Abaimov, D; Budygin, E; Deal, A; Evdokimenko, A; Fedorova, T; Gainetdinov, R; Kazanskaya, R; Lopachev, A; Lopacheva, O; Timoshina, Y; Volnova, A | 1 |
| Dal-Pont, GC; Gava, FF; Quevedo, J; Resende, WR; Tye, SJ; Valvassori, SS; Varela, RB | 1 |
| Bernklau, S; Friedrich, U; Plössl, K; Schmid, C; Schmid, V; Weber, BHF | 1 |
| Aleixo, RC; Cabral, VR; Campos, MLA; Cavalcante, FJP; da Silva Faustino, R; da Silva, JMC; das Neves Azevedo, A; de Albuquerque, LZ; Gomes, LRO; Paiva, LS; Teixeira, MP | 1 |
| Chen, L; Hu, Y; Li, J; Yue, J; Zhou, S | 1 |
| An, HF; Chen, YM; He, JC; Hu, YH; Jiang, C; Ke, XY; Li, LL; Liu, LZ; Liu, YY; Lu, QY; Qin, SQ; Sun, N; Wang, Y; Xian, XH; Zhang, LN | 1 |
| Budni, J; Dal-Pont, GC; Gava, FF; Mina, FG; Quevedo, J; Resende, WR; Valvassori, SS; Varela, RB | 1 |
| Cai, L; Collins, DM; Duan, Q; King, C; Kutz, LC; Lingrel, JB; Marck, PV; Pessoa, MT; Pierre, SV; Tian, J; Wang, X; Xie, JX; Xie, Z; Xu, Y; Yan, Y | 1 |
| Janković, R; Prostran, M; Radenković, M; Stojanović, M | 1 |
| Guan, HX; Hua, QQ; Jiang, Y; Liao, H; Xiao, BK; Yang, K; Zhang, ZJ; Zhou, T | 1 |
| Cararo, JH; Carvalho, AF; Dal-Pont, GC; Gava, FF; Mina, FG; Peterle, BR; Quevedo, J; Resende, WR; Valvassori, SS; Varela, RB | 1 |
| Balaram, P; Chambers, AR; Kaczmarek, LK; Large, CH; Pilati, N; Polley, DB | 1 |
| Cohen Ben-Ami, H; Hodes, A; Lichtstein, D; Lifschytz, T; Rosen, H | 1 |
| Duan, Q; Kalisz, J; Marck, PV; Morgan, EE; Pierre, SV; Xu, Y | 1 |
| Drummond, CA; Fan, X; Haller, ST; Kennedy, DJ; Liu, J; Tian, J | 1 |
| Lovel, AG; Mitchell, DM; Stenkamp, DL | 1 |
| Ami, HC; Beeri, R; Buzaglo, N; Golomb, M; Langane, F; Lichtstein, D; Pierre, S; Rosen, H | 1 |
| Huang, ACW; Tsai, ML; Wang, YC; Yu, YH | 1 |
| Atella, GC; Barbosa, LA; Cortes, VF; De Lima Santos, H; De Souza Busch, M; Garcia, IJP; Kinoshita, PF; Scavone, C; Silva, LNDE | 1 |
| Hisatsune, A; Kajiwara, Y; Katsuki, H; Kurauchi, Y; Matsuda, K; Seki, T; Yamada, T; Yoshimaru, Y | 1 |
| Bianchini, G; Dal-Pont, GC; Gava, FF; Peterle, BR; Quevedo, J; Resende, WR; Trajano, KS; Valvassori, SS; Varela, RB | 1 |
| Huang, AC; Huang, CL; Wang, CC; Wang, EN; Wang, YC | 2 |
| Abushik, PA; Antonov, SM; Eaton, MJ; Sibarov, DA; Skatchkov, SN | 1 |
| Aperia, A; Arvidsson, I; Brismar, H; Burlaka, I; Karpman, D; Liu, XL; Rebetz, J; Yang, L | 1 |
| Garvin, JL; Gonzalez-Vicente, A | 1 |
| Edge, AS; Lang, H; Liberman, MC; Polley, DB; Shi, F; Tong, M; Yin, Y; Yuan, Y | 1 |
| Houkin, K; Kuroda, S; Saito, H; Shichinohe, H; Yamauchi, T | 1 |
| Lou, H; Su, P; Wan, Y; Xue, T; Yang, YH | 1 |
| Chen, L; Chen, X; Deng, L; Lu, Y; Lv, L; Man, J; Shan, H; Wang, Y; Wu, Y; Zhao, D; Zhou, Y | 1 |
| Boeira, SP; Bortolatto, CF; Jesse, CR; Nogueira, CW; Souza, LC; Wilhelm, EA | 1 |
| Chen, FQ; Chen, J; Chen, X; Chen, XD; Chen, Y; Ding, ZJ; Lin, Y; Mi, WJ; Qiu, JH; Wang, J; Wang, RF; Wang, X; Wang, Y; Yue, B; Zhang, PZ | 1 |
| Arent, CO; Budni, J; Jornada, LK; Kapczinski, F; Mariot, E; Quevedo, J; Steckert, AV; Tonin, PT; Valvassori, SS; Varela, RB | 1 |
| Bianchi, G; Ferrandi, M; Ferrari, P; Manunta, P; Molinari, I; Rastaldi, MP | 1 |
| Chertoff, ME; Diaz, FJ; Earl, BR; Kamerer, AM; Peppi, M; Sorensen, JL; Thomas, ML | 1 |
| Lopes-Borges, J; Mariot, E; Quevedo, J; Teixeira, AL; Tonin, PT; Valvassori, SS; Varela, RB | 1 |
| Gonçalves, CL; Lopes-Borges, J; Quevedo, J; Streck, EL; Tonin, PT; Valvassori, SS; Varela, RB; Vieira, JS | 1 |
| Amboni, RT; Bianchini, G; Dal-Pont, GC; Lopes-Borges, J; Mariot, E; Quevedo, J; Valvassori, SS; Varela, RB | 1 |
| Davel, AP; Kawamoto, EM; Kinoshita, PF; Lima, Lde S; Orellana, AM; Rossoni, LV; Scavone, C; Vasconcelos, AR; Yshii, LM | 1 |
| Gao, L; He, Y; Jin, X; Kong, D; Li, J; Lou, G; Wang, X; Wang, Y; Xia, B; Zhang, L; Zhao, B | 1 |
| Li, Y; Zhou, GM | 1 |
| Domanska-Janik, K; Gornicka-Pawlak, E; Jablonska, A; Janowski, M; Sypecka, J | 1 |
| Ark, M; Aypar, E; Demirtaş, A; Gözübüyük, G; Ozdemir, A; Şahan, G; Turan, NN | 1 |
| Dal-Pont, GC; de Souza, CT; Lopes-Borges, J; Luz, G; Mariot, E; Quevedo, J; Resende, WR; Valvassori, SS; Vitto, MF | 1 |
| Chen, L; Han, X; Hu, Y; Li, J; Wu, H; Yang, J; Yue, J | 1 |
| Blanco, G; Calvet, JP; Jansson, K; Magenheimer, BS; Reif, GA; Sánchez, G; Venugopal, J; Wallace, DP | 1 |
| Drela, K; Jablonska, A; Janowski, M; Lukomska, B; Wojcik-Stanaszek, L; Zalewska, T | 1 |
| Arent, CO; Carvalho, AF; Dal-Pont, GC; Lopes-Borges, J; Mariot, E; Quevedo, J; Resende, WR; Steckert, AV; Valvassori, SS; Varela, RB | 1 |
| Amodeo, DA; Dwivedi, Y; Grospe, G; Ragozzino, ME; Zang, H | 1 |
| Deutsch, J; Einat, H; Hodes, A; Lichtstein, D; Lifschytz, T; Rosen, H | 1 |
| Ando, K; Barth, JL; Brown, LN; Lang, H; LaRue, AC; Nishimoto, E; Noble, KV; Schulte, BA; Xing, Y | 1 |
| Chambers, AR; Polley, DB; Salazar, JJ | 1 |
| Carvalho, AF; Dal-Pont, GC; de Souza, CT; Farias, HR; Jornada, LK; Machado, AG; Peterle, BR; Quevedo, J; Resende, WR; Valvassori, SS | 1 |
| Domanska-Janik, K; Gielecki, J; Gornicka-Pawlak, E; Janowski, M; Kozlowska, H; Lukomska, B | 1 |
| Du, ZM; Gao, Y; Li, DL; Liu, Y; Lu, YJ; Sun, HL; Wang, LY; Wang, YP; Yang, BF | 1 |
| Blaustein, MP; Chen, L; Hamlyn, JM; Iwamoto, T; Izuka, M; Kinsey, SP; Kotlikoff, MI; Lingrel, JB; Philipson, KD; Raina, H; Song, H; Wier, WG; Zhang, J | 1 |
| Dean, S; Dostanic-Larson, I; Hou, X; Lingrel, JB; Moseley, AE; Theriault, SF; Van Huysse, JW; Wu, H | 1 |
| El-Mallakh, RS; Gao, Y; Hamid, H; Hougland, MT; Lei, Z | 1 |
| Amin, MS; Leenen, FH; Reza, E; Wang, H | 1 |
| Chen, LP; Chen, W; Han, HM; Li, DL; Liu, Y; Pan, ZY; Qi, HP; Sun, HL; Wang, LY; Xie, J; Zhao, WM | 1 |
| Bagrov, AY; Cooper, CJ; El-Okdi, N; Elkareh, J; Fedorova, OV; Gohara, S; Gupta, S; Haller, S; Malhotra, D; Periyasamy, SM; Shapiro, JI; Shidyak, A; Taleb, M; Tian, J; Xie, Z | 1 |
| Corrêa, C; Ferreira, GK; Freitas, TP; Moretti, M; Quevedo, J; Rezin, GT; Santos, PM; Scaini, G; Streck, EL; Valvassori, SS | 1 |
| Arent, CO; Ferreira, CL; Fries, GR; Jornada, LK; Kapczinski, F; Moretti, M; Padilha, PT; Quevedo, J; Valvassori, SS | 1 |
| Belliard, A; Garlid, KD; Li, Z; Morgan, EE; Pierre, SV; Salari, B; Stebal, C; Tennyson, G | 1 |
| Andrade, VM; Arent, CO; Damiani, AA; Ferreira, CL; Hainzenreder, G; Jornada, LK; Leffa, D; Moretti, M; Quevedo, J; Valvassori, SS | 1 |
| Ferrari, P | 1 |
| Ahn, YM; Kim, SH; Kim, YS; Park, HG; Yu, HS | 2 |
| Fasching, A; Fujita, T; Hansell, P; Kawakami, T; Nangaku, M; Nishijima, F; Nordquist, L; Palm, F; Tanaka, T | 1 |
| Arent, CO; Dal-Pizzol, F; Ferreira, CL; Jornada, LK; Mina, F; Moretti, M; Quevedo, J; Steckert, AV; Valvassori, SS | 1 |
| Brocardo, PS; Budni, J; Dafre, AL; Franco, JL; Pavesi, E; Rodrigues, AL; Terenzi, MG; Trevisan, R; Uliano-Silva, M | 1 |
| Goddard, JC; Kilpatrick, LA; Krug, EL; Lang, H; Li, M; Samuvel, DJ; Zhu, J | 1 |
| Clausen, T; Hofman-Bang, J; Lewin, E; Martuseviciene, G; Olgaard, K | 1 |
| Banerjee, P; El-Mallakh, RS; Gao, Y; Herman, L; Hougland, T; Lei, Z; Lord, J; Payne, RS; Schurr, A | 1 |
| Calderon, DP; Fremont, R; Khodakhah, K; Kraenzlin, F | 1 |
| Aperia, A; Khodus, GR; Kruusmägi, M; Li, J; Liu, XL | 1 |
| Cho, HH; Cho, YB; Jang, S; Jeong, HS; Park, JS | 1 |
| Beierwaltes, WH; Damhoff, T; Lasko, VM; Lingrel, JB; Lorenz, JN; Nieman, ML; Prasad, V | 1 |
| Dostanic, I; Hou, X; Lingrel, JB; Van Huysse, JW; Wu, H | 1 |
| Burns, DK; Cannon, SC; Fu, Y; Gray, HF; Mi, W; Struyk, AF; Wu, F | 1 |
| Kilpatrick, LA; Lang, H; Lee, FS; Zhu, J | 1 |
| Carmines, PK; Pollock, JS; Yang, J | 1 |
| Cui, XP; Gao, HQ; Ji, X; Liu, XJ; Qiu, J; Wang, Y; You, BA; Zhao, SH | 1 |
| Gupta, S; Liu, J; Malhotra, D; Najjar, SM; Shapiro, JI; Xie, Z; Yan, Y | 1 |
| Bai, DL; Bo, YX; Chen, WZ; Dong, YL; Hu, ZL; Kang, AL; Sun, WK; Wang, W; Wang, YP | 1 |
| Alves, AK; Amorim, FM; Jacob, PL; Leite, JA; Néris, PL; Oliveira, MR; Rodrigues, YK; Rodrigues-Mascarenhas, S | 1 |
| Dalsgaard, T; Kroigaard, C; Kudryavtseva, O; Olesen, SP; Simonsen, U; Wandall-Frostholm, C | 1 |
| Akiyama, T; Kawada, T; Miyamoto, T; Mori, H; Sugimachi, M; Sunagawa, K; Uemura, K; Yamazaki, T | 1 |
| Decker, S; El-Mallakh, RS; El-Masri, MA; Huff, MO; Levy, RS; Li, XP | 1 |
| Hongo, K; Nakazato, F; Tada, T; Tanaka, Y; Zhan, H | 1 |
| Adir, Y; Azzam, ZS; Comellas, A; Crespo, A; Dada, LA; Krivoy, N; Lecuona, E; Ridge, KM; Rutschman, DH; Sznajder, JI | 1 |
| Ghofrani, HA; Grimminger, F; Kohstall, MG; Morty, RE; Olschewski, A; Seeger, W; Vadász, I | 1 |
| Avila, TT; Kapczinski, F; Machado-Vieira, R; Portela, LV; Schmidt, AP; Soares, JC; Souza, DO | 1 |
| Carmona, C; Negri, G; Peña, C; Reinés, A; Rodríguez de Lores Arnaiz, G; Zárate, S | 1 |
| Büyükuysal, RL | 1 |
| Danchuk, S; Ianosi-Irimie, M; Kamano, Y; Nogawa, T; Pettit, GR; Puschett, JB; Rabon, E; Vu, H; Wiese, T | 1 |
| Bernardi, G; Calabresi, P; Costa, C; Martella, G; Mercuri, NB; Pisani, A; Shen, J; Tscherter, A | 1 |
| Galili, D; Goldstein, I; Levy, T; Lichtstein, D; Ovadia, H; Rosen, H; Yirmiya, R | 1 |
| Decker, S; El-Mallakh, RS; El-Masri, MA; Huff, MO; Levy, RS; Li, XP; Morris, M | 1 |
| Haddy, FJ | 1 |
| Gao, Z; Kehoe, V; Li, J; Sinoway, LI | 1 |
| Costa, AD; Dos Santos, P; Garlid, KD; Pasdois, P; Pierre, SV; Quinlan, CL; Rissa, A; Tariosse, L; Vinassa, B | 1 |
| Dugladze, T; Gloveli, T; Heinemann, U; Kehrer, C; Maziashvili, N; Schmitz, D; Wójtowicz, A | 1 |
| Bełtowski, J; Borkowska, E; Marciniak, A; Wójcicka, G | 1 |
| Hashino, E; Kondo, T; Matsuoka, AJ; Miyamoto, RT | 1 |
| Alkadhi, K; Alzoubi, K | 1 |
| El-Mallakh, RS; Herman, L; Hougland, T | 1 |
| Chen, X; Dohi, S; Zeng, W | 1 |
| Aronsen, JM; Birkeland, JA; Enger, UH; Louch, WE; Sejersted, OM; Sjaastad, I; Swift, F; Tovsrud, N | 1 |
| Chambers, AF; Wilson, SM | 1 |
| Mitrovic, DM; Petrovic, MM; Rosic, G; Scepanovic, L | 1 |
| Fujimoto, S; Funakoshi, S; Inagaki, N; Kominato, R; Mukai, E; Nabe, K; Nakamura, Y; Nishi, Y; Seino, Y; Shimodahira, M | 1 |
| Goddard, JC; Hedrick, M; Lang, H; Schmiedt, RA; Schulte, BA; Schulte, JB; Wei, L | 1 |
| Dostanic-Larson, I; Lasko, V; Lingrel, JB; Loreaux, EL; Lorenz, JN; Paul, RJ; Schnetzer, JR | 1 |
| Dwivedy, AK; Shah, SN | 1 |
| Haddy, FJ; Pamnani, MB | 1 |
| de Estable-Puig, RF; Estable-Puig, JF; Manz, HJ | 1 |
| Carlson, GP; Fossa, AA | 1 |
| Aonuma, K; Benson, J; Gosselin, AJ; Iesaka, Y; Lister, JW; Pinakatt, T; Rozanski, JJ; Sampsell, R; Stanford, W | 1 |
| Horie, R; Igawa, T; Ikeda, K; Kanbe, T; Kihara, M; Mori, K; Nara, Y; Yamori, Y | 1 |
| Varma, DR | 1 |
| Haruno, A; Hashimoto, K | 1 |
| Awaji, T; Haruno, A; Hashimoto, K; Hirasawa, A; Hosono, M | 1 |
| Ichihara, K; Nakai, T | 1 |
| Bardisa, L; Martín, N; Pantoja, C; Quezada, P; Valenzuela, J; Vargas, M | 1 |
| Abe, H; Awaji, T; Hashimoto, K; Motomura, S; Wu, Z | 1 |
| Bachmann, J; Barenbrock, M; Ganten, D; Rahn, KH; Spieker, C; Tepel, M; Theilmeier, G; Zidek, W | 1 |
| Changaris, DG; el-Mallakh, RS; Harrison, LT; Levy, RS; Li, R | 1 |
| Brooks, RR; Carpenter, JF; Maynard, AE; Miller, KE | 1 |
| Ando, K; Fujita, T; Shimosawa, T | 1 |
| Chen, WJ; Huang, HC; Lee, YT; Lin-Shiau, SY | 1 |
| Bergk, A; Bruer, U; Dirnagl, U; Isaev, NK; Meisel, A; Ruscher, K; Trendelenburg, G; Victorov, IV; Weih, MK; Wiegand, F | 1 |
| Buffin-Meyer, B; Cheval, L; Doucet, A; Le Moal, C; Marsy, S; Verbavatz, JM; Younes-Ibrahim, M | 1 |
| Lu, Z; Wang, H; Yuan, W | 1 |
| Blackband, SJ; Buckley, DL; Bui, JD; Inglis, BA; Phillips, MI; Plant, HD; Zelles, T | 1 |
| Ghai, R; Haddy, FJ; Pamnani, MB; Schooley, JF; Swindall, BT | 1 |
| Barbey, O; Bourdeaux, M; Duran, MJ; Lévy, S; Maixent, JM; Pierre, S; Ricard, P; Sennoune, S | 1 |
| Cobb, M; Decker, S; El-Mallakh, RS; Grider, G; Huff, MO; Levy, RS; Li, XP | 1 |
| Apkon, M; Berul, CI; Ingwall, JS; O'Brien, SE; Patel, HT; Saupe, K; Spindler, M; Zahler, R | 1 |
| Bessou, C; Franks, CJ; Gieseler, K; Holden-Dye, L; Mariol, MC; Migaud, M; Ségalat, L | 1 |
| Maixentt, JM; Mougenot, R; Paganelli, F | 1 |
| Aileru, AA; De Albuquerque, A; Hamilton, MJ; Hamlyn, JM; Manunta, P; Shah, JR; Weinreich, D | 1 |
| Pinto, VD; Rossoni, LV; Vassallo, DV | 1 |
| Bar, PR; Bisogno, T; Di Marzo, V; Fezza, F; Nicolay, K; van der Stelt, M; van Haaften, GW; Veldhuis, WB; Veldink, GA; Vliegenthart, JF | 1 |
| Mózsik, G; Vizi, F | 1 |
| Aryanpur, I; Paydar, M; Reyhani, F; Shakibi, JG; Siassi, B | 1 |
| Sedlácek, J | 1 |
| Alousi, AA; Santa Barbara, L | 1 |
| Evenou, JP; Hof, A; Hof, RP; Novosel, D | 1 |
| Ditto, WL; Garfinkel, A; Spano, ML; Weiss, JN | 1 |
| Beile, A; Guttmann, I; Osikowska-Evers, B; Peters, T; Scheufler, E; Tegtmeier, F; Urenjak, J; Wilffert, B | 1 |
| McClain, JM; Wang, W; Zucker, IH | 1 |
| Haruno, A; Hashimoto, K; Hirasawa, A; Matsuzaki, T; Sugiyama, A | 1 |
| Wang, W; Zucker, IH | 1 |
| Thomas, GP; Varma, RK | 1 |
| Barrigón, S; Salinas, P | 1 |
| Arancibia, S; Litovsky, B | 1 |
| Akiyama, K; Hashimoto, K | 1 |
| Barron, KD; Cragoe, EJ; Kimelberg, HK; Rose, JW; Waniewski, RA | 1 |
| Anversa, P; Capasso, JM; Olivetti, G | 1 |
| Brooks, RR; Carpenter, JF; Gregory, CM; Jones, SM | 1 |
| Hilton, PJ | 1 |
| Gibson, JK; Lucchesi, BR; Patterson, E | 1 |
| Altman, S; Simon, G | 1 |
| Dzau, VJ; Gibbons, GH; Nabel, EG | 1 |
| Petsche, H; Rappelsberger, P; Trappl, R | 1 |
| Cosnier, D; Duchêne-Marullaz, P; Grimal, J | 1 |
| Cheymol, G; Gilbert, JC; Laubie, M; Mouillé, P; Schmitt, H | 1 |
| Petsche, H; Rappelsberger, P | 1 |
| Appel, SH; Escueta, AV | 1 |
| Isono, C; Sakai, K; Sugano, S | 1 |
| Barbeau, A; Donaldson, J | 1 |
| Alousi, AA; Beards, JA | 1 |
| Creutzfeldt, OD | 1 |
| Brody, IA | 1 |
| Iwatsuka, H; Matsuo, T; Suzuoki, Z; Taketomi, S | 1 |
| Burney, RG; DiFazio, CA; Peach, MJ; Petrie, KA; Silvester, MJ | 1 |
| Stickney, JL | 1 |
| Alexianu, D; Arseni, C; Bacalbaşa, N; Slăvescu, D | 1 |
| Puri, PS | 1 |
| Inczinger, F; Kozlovský, J | 1 |
| Baum, T; Eckfeld, DK; Rowles, G; Shropshire, AT; Varner, LL | 1 |
| Allen, JD; Shanks, RG; Zaidi, SA | 1 |
| Brown, HD; Chattopadhyay, SK; Patel, AB | 1 |
| Kośmider, S; Smolarz, W | 1 |
9 review(s) available for ouabain and Disease Models, Animal
| Article | Year |
|---|---|
The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension.
Topics: Animals; Disease Models, Animal; Humans; Hypertension; Ouabain; Signal Transduction; Sodium Chloride; Sodium-Calcium Exchanger; Sodium-Potassium-Exchanging ATPase | 2009 |
Rostafuroxin: an ouabain-inhibitor counteracting specific forms of hypertension.
Topics: Androstanols; Animals; Antihypertensive Agents; Blood Pressure; Calmodulin-Binding Proteins; Clinical Trials, Phase II as Topic; Disease Models, Animal; ErbB Receptors; Humans; Hypertension; Kidney; Mutation; Ouabain; Polymorphism, Genetic; Signal Transduction; Sodium; Sodium-Potassium-Exchanging ATPase; src-Family Kinases | 2010 |
Calcium signaling triggered by ouabain protects the embryonic kidney from adverse developmental programming.
Topics: Animals; Calcium Signaling; Diet, Protein-Restricted; Disease Models, Animal; Enzyme Inhibitors; Female; Fetal Nutrition Disorders; Humans; Inositol 1,4,5-Trisphosphate Receptors; Kidney; Maternal Nutritional Physiological Phenomena; Organogenesis; Ouabain; Pregnancy; Rats; Sodium-Potassium-Exchanging ATPase | 2011 |
Role of dietary salt in hypertension.
Topics: Animals; Blood Pressure; Diet, Sodium-Restricted; Disease Models, Animal; Enzyme Inhibitors; Humans; Hypertension; Ouabain; Sodium Chloride, Dietary; Sodium-Potassium-Exchanging ATPase | 2006 |
Role of long-term potentiation of sympathetic ganglia (gLTP) in hypertension.
Topics: Aging; Animals; Blood Pressure; Disease Models, Animal; Electric Stimulation; Ganglia, Sympathetic; Humans; Hypertension; Long-Term Potentiation; Obesity; Ouabain; Rats; Rats, Inbred SHR; Rats, Zucker; Receptors, Serotonin; Stress, Psychological | 2007 |
Mimicking human bipolar ion dysregulation models mania in rats.
Topics: Animals; Bipolar Disorder; Cardenolides; Disease Models, Animal; Enzyme Inhibitors; Humans; Hyperkinesis; Injections, Intraventricular; Ion Transport; Ouabain; Rats; Sodium-Potassium-Exchanging ATPase | 2007 |
[Pathology of cerebral edema. II. Experimental models and modifying agents].
Topics: Animals; Brain Edema; Brain Injuries; Brain Ischemia; Brain Neoplasms; Cats; Disease Models, Animal; Freezing; Hypertension; Hypotonic Solutions; Ouabain; Radiation Injuries, Experimental; Rats; Triethyltin Compounds | 1981 |
Cellular sodium transport in essential hypertension.
Topics: Animals; Biological Transport; Disease Models, Animal; Drug Resistance; Erythrocytes; Humans; Hypertension; Leukocytes; Lithium; Models, Biological; Natriuretic Agents; Ouabain; Sodium; Sodium-Potassium-Exchanging ATPase | 1986 |
Pathophysiology of experimental renovascular hypertension.
Topics: Acute Disease; Angiotensin II; Animals; Arterial Occlusive Diseases; Central Nervous System; Chronic Disease; Disease Models, Animal; Dogs; Hemodynamics; Hypertension, Renovascular; Kidney; Ouabain; Perfusion; Rats; Renin-Angiotensin System; Sympathetic Nervous System; Vasoconstriction; Vasopressins | 1985 |
186 other study(ies) available for ouabain and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Comparative Therapeutic Potential of Cardioactive Glycosides in Doxorubicin Model of Heart Failure.
Topics: Animals; Cardenolides; Cardiac Glycosides; Cardiotonic Agents; Cardiotoxicity; Digoxin; Disease Models, Animal; Doxorubicin; Heart Failure; Ouabain; Rats, Wistar; Recovery of Function; Stroke Volume; Ventricular Function, Left; Ventricular Remodeling | 2022 |
Ouabain inhibitor rostafuroxin attenuates dextromethorphan-induced manic potential.
Topics: Androstanols; Animals; Bipolar Disorder; Dextromethorphan; Disease Models, Animal; Locomotion; Male; Mice; Ouabain; Signal Transduction | 2021 |
Imipramine induces hyperactivity in rats pretreated with ouabain: Implications to the mania switch induced by antidepressants.
Topics: Animals; Antidepressive Agents; Disease Models, Animal; Humans; Imipramine; Mania; Ouabain; Rats; Rats, Wistar | 2022 |
A real-time PCR method to genotype mutant mouse models with altered affinity for cardiotonic steroids on the Na,K-ATPase.
Topics: Animals; Cardiac Glycosides; Disease Models, Animal; Genotype; Mice; Ouabain; Protein Isoforms; Real-Time Polymerase Chain Reaction; Sodium-Potassium-Exchanging ATPase | 2022 |
Ouabain modulates airway remodeling caused by Th2-high asthma in mice.
Topics: Airway Remodeling; Animals; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Budesonide; Cytokines; Disease Models, Animal; Immunoglobulin E; Inflammation; Lung; Mice; Mice, Inbred BALB C; Ouabain; Ovalbumin | 2022 |
Depressive-like behavior accompanies neuroinflammation in an animal model of bipolar disorder symptoms induced by ouabain.
Topics: Adenosine Triphosphatases; Animals; Behavior, Animal; Bipolar Disorder; Disease Models, Animal; Male; Mania; Neuroinflammatory Diseases; Ouabain; Rats; Rats, Wistar | 2022 |
Folic acid does not have an anti-manic effect but protect the brain against oxidative stress in an animal model of mania induced by ouabain.
Topics: Animals; Antimanic Agents; Behavior, Animal; Brain; Disease Models, Animal; Folic Acid; Lithium; Male; Mania; Ouabain; Oxidative Stress; Rats; Rats, Wistar | 2023 |
Ouabain enhances renal cyst growth in a slowly progressive mouse model of autosomal dominant polycystic kidney disease.
Topics: Adenosine Triphosphatases; Animals; Cysts; Disease Models, Animal; Female; Hormones; Kidney; Male; Mice; Ouabain; Polycystic Kidney, Autosomal Dominant; TRPP Cation Channels | 2023 |
Intracerebroventricular injection of ouabain causes mania-like behavior in mice through D2 receptor activation.
Topics: Animals; Behavior, Animal; Bipolar Disorder; Corpus Striatum; Disease Models, Animal; Dopamine; Glycogen Synthase Kinase 3 beta; Humans; Male; Mice; Ouabain; Receptors, Dopamine D2; Sodium-Potassium-Exchanging ATPase | 2019 |
HDAC inhibitors reverse mania-like behavior and modulate epigenetic regulatory enzymes in an animal model of mania induced by Ouabain.
Topics: Animals; Behavior, Animal; Bipolar Disorder; Butyric Acid; Corpus Striatum; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferases; Frontal Lobe; Hippocampus; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Locomotion; Male; Mania; Ouabain; Rats; Rats, Wistar; Signal Transduction; Treatment Outcome; Valproic Acid | 2020 |
Retinoschisin and Cardiac Glycoside Crosstalk at the Retinal Na/K-ATPase.
Topics: Animals; Cells, Cultured; Digoxin; Disease Models, Animal; Eye Proteins; Humans; Immunohistochemistry; Mice, Inbred C57BL; Ouabain; Protein Binding; Retinoschisis; Signal Transduction; Sodium-Potassium-Exchanging ATPase | 2020 |
Ouabain pre-treatment modulates B and T lymphocytes and improves survival of melanoma-bearing animals.
Topics: Animals; Antineoplastic Agents; B-Lymphocytes; Disease Models, Animal; Female; Humans; Immunomodulation; Injections, Intraperitoneal; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Ouabain; Skin Neoplasms; T-Lymphocytes, Regulatory | 2020 |
Ouabain Protects Nephrogenesis in Rats Experiencing Intrauterine Growth Restriction and Partially Restores Renal Function in Adulthood.
Topics: Animal Nutritional Physiological Phenomena; Animals; Blood Pressure; Diet, Protein-Restricted; Disease Models, Animal; Female; Fetal Growth Retardation; Male; Malnutrition; Maternal Nutritional Physiological Phenomena; Nephrons; Nutritional Status; Ouabain; Pregnancy; Proteinuria; Rats, Sprague-Dawley; Recovery of Function; Regeneration; Sodium Chloride, Dietary | 2021 |
Na
Topics: Animals; Brain Ischemia; Disease Models, Animal; Infarction, Middle Cerebral Artery; Male; Ouabain; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sodium-Potassium-Exchanging ATPase; Vesicular Glutamate Transport Protein 1 | 2021 |
Ouabain induces memory impairment and alter the BDNF signaling pathway in an animal model of bipolar disorder: Cognitive and neurochemical alterations in BD model.
Topics: Animals; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Cognition; Disease Models, Animal; Hippocampus; Humans; Ouabain; Rats; Rats, Wistar; Signal Transduction | 2021 |
Cardiac Oxidative Signaling and Physiological Hypertrophy in the Na/K-ATPase α1
Topics: Angiotensin II; Animals; Cardiac Glycosides; Cardiomegaly; Disease Models, Animal; Echocardiography; Heart; Male; Mice; Mutation; Myocardium; Ouabain; Protein Isoforms; Reactive Oxygen Species; RNA-Seq; Signal Transduction; Sodium-Potassium-Exchanging ATPase | 2021 |
Clarification of serotonin-induced effects in peripheral artery disease observed through the femoral artery response in models of diabetes and vascular occlusion: The role of calcium ions.
Topics: Animals; Calcium; Diabetes Complications; Disease Models, Animal; Femoral Artery; Nifedipine; Ouabain; Peripheral Arterial Disease; Rats; Rats, Wistar; Serotonin; Vasoconstriction | 2017 |
Dose-dependent effects of ouabain on spiral ganglion neurons and Schwann cells in mouse cochlea.
Topics: Animals; Cochlea; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Hair Cells, Auditory; Hearing Loss, Central; Hearing Loss, Sensorineural; Mice; Ouabain; Schwann Cells; Spiral Ganglion | 2017 |
Lithium and Tamoxifen Modulate Behavior and Protein Kinase C Activity in the Animal Model of Mania Induced by Ouabain.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Bipolar Disorder; Brain; Disease Models, Animal; Drug Administration Routes; Enzyme Inhibitors; Lithium; Locomotion; Male; Ouabain; Protein Kinase C; Rats; Rats, Wistar; Tamoxifen | 2017 |
Pharmacological modulation of Kv3.1 mitigates auditory midbrain temporal processing deficits following auditory nerve damage.
Topics: Action Potentials; Animals; Auditory Pathways; Auditory Perception; Cochlear Nerve; Compulsive Behavior; Disease Models, Animal; Imidazoles; Membrane Transport Modulators; Mesencephalon; Mice; Models, Biological; Neurons; Ouabain; Pyrimidines; Recovery of Function; Shaw Potassium Channels; Tissue Culture Techniques; Vestibulocochlear Nerve Diseases | 2017 |
Reduction in endogenous cardiac steroids protects the brain from oxidative stress in a mouse model of mania induced by amphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Antibodies; Antioxidants; Bipolar Disorder; Brain; Central Nervous System Stimulants; Disease Models, Animal; Male; Mice, Inbred BALB C; Motor Activity; Neuroprotective Agents; Ouabain; Oxidative Stress; Random Allocation | 2018 |
Preconditioning and Postconditioning by Cardiac Glycosides in the Mouse Heart.
Topics: Animals; Cardiotonic Agents; Cell Death; Digoxin; Disease Models, Animal; Enzyme Inhibitors; Isolated Heart Preparation; Male; Mice, Inbred C57BL; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Ouabain; Protein Kinase C-epsilon; Recovery of Function; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Ventricular Function, Left; Ventricular Pressure | 2018 |
Na/K-ATPase signaling mediates miR-29b-3p regulation and cardiac fibrosis formation in mice with chronic kidney disease.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Down-Regulation; Fibrosis; Humans; Male; Mice; MicroRNAs; Myocardium; Nitriles; Ouabain; Renal Insufficiency, Chronic; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Sulfones | 2018 |
Dynamic changes in microglial and macrophage characteristics during degeneration and regeneration of the zebrafish retina.
Topics: Animals; Animals, Genetically Modified; Disease Models, Animal; Enzyme Inhibitors; Female; Green Fluorescent Proteins; In Situ Nick-End Labeling; Luminescent Proteins; Macrophages; Male; Membrane Glycoproteins; Membrane Proteins; Microfilament Proteins; Microglia; Nerve Degeneration; Neutrophil Infiltration; Ouabain; Protein Kinase C; Red Fluorescent Protein; Regeneration; Retina; Zebrafish; Zebrafish Proteins | 2018 |
Augmentation of Ouabain-Induced Increase in Heart Muscle Contractility by Akt Inhibitor MK-2206.
Topics: Animals; Cardiotonic Agents; Cells, Cultured; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Heterocyclic Compounds, 3-Ring; Isolated Heart Preparation; Male; Myocardial Contraction; Myocardial Infarction; Myocytes, Cardiac; Ouabain; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats, Wistar; Signal Transduction; Ventricular Function, Left | 2019 |
Motor function in an animal model with ouabain-induced bipolar disorder and comorbid anxiety behavior.
Topics: Akathisia, Drug-Induced; Animals; Anxiety; Behavior, Animal; Bipolar Disorder; Comorbidity; Disease Models, Animal; Male; Ouabain; Psychomotor Performance; Rats; Rats, Wistar | 2018 |
Ouabain attenuates oxidative stress and modulates lipid composition in hippocampus of rats in lipopolysaccharide-induced hypocampal neuroinflammation in rats.
Topics: Animals; Catalase; Disease Models, Animal; Glutathione; Glutathione Peroxidase; Hippocampus; Humans; Inflammation; Lipid Peroxidation; Lipopolysaccharides; Membrane Lipids; Nervous System; Ouabain; Oxidative Stress; Protein Carbonylation; Rats; Superoxide Dismutase | 2019 |
Na
Topics: Animals; Chlorpromazine; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Genes, fos; Haloperidol; Impulsive Behavior; Infusions, Intraventricular; Locomotion; Male; Mice; Mice, Inbred C57BL; Neuroglia; Ouabain; Prefrontal Cortex; Receptors, Dopamine D2; Signal Transduction; Sodium-Potassium-Exchanging ATPase | 2019 |
Tamoxifen has an anti-manic effect but not protect the brain against oxidative stress in an animal model of mania induced by ouabain.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Brain; Disease Models, Animal; Male; Ouabain; Oxidative Stress; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Tamoxifen | 2019 |
Effects of lithium and carbamazepine on spatial learning and depressive behavior in a rat model of bipolar disorder induced by ouabain.
Topics: Animals; Bipolar Disorder; Carbamazepine; Depression; Disease Models, Animal; Learning; Lithium; Male; Ouabain; Rats; Rats, Wistar | 2013 |
Kainate-induced calcium overload of cortical neurons in vitro: Dependence on expression of AMPAR GluA2-subunit and down-regulation by subnanomolar ouabain.
Topics: Adamantane; Animals; Calcium; Calcium Signaling; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Female; In Vitro Techniques; Kainic Acid; Nerve Degeneration; Neurons; Ouabain; Patch-Clamp Techniques; Piperidines; Pregnancy; Rats; Rats, Wistar; Receptors, AMPA | 2013 |
Ouabain protects against Shiga toxin-triggered apoptosis by reversing the imbalance between Bax and Bcl-xL.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Caspase 3; Caspase 8; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Inositol 1,4,5-Trisphosphate Receptors; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Ouabain; Rats; Rats, Sprague-Dawley; Shiga Toxin 2; Signal Transduction; Sodium-Potassium-Exchanging ATPase | 2013 |
Angiotensin II-induced hypertension increases plasma membrane Na pump activity by enhancing Na entry in rat thick ascending limbs.
Topics: Angiotensin II; Animals; Disease Models, Animal; Hypertension; Loop of Henle; Male; Ouabain; Rats; Rats, Sprague-Dawley; Sodium; Sodium-Potassium-Exchanging ATPase | 2013 |
Ouabain-induced cochlear nerve degeneration: synaptic loss and plasticity in a mouse model of auditory neuropathy.
Topics: Animals; Cochlea; Cochlear Nerve; Disease Models, Animal; Enzyme Inhibitors; Female; Mice; Mice, Inbred CBA; Nerve Degeneration; Neuronal Plasticity; Organ of Corti; Ouabain; Presynaptic Terminals; Receptors, Glutamate; Synapses; Time Factors; Vestibulocochlear Nerve Injuries | 2014 |
Bone marrow stromal cell transplantation enhances recovery of motor function after lacunar stroke in rats.
Topics: Animals; Disease Models, Animal; Green Fluorescent Proteins; Magnetic Resonance Imaging; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Motor Activity; Nerve Tissue Proteins; Ouabain; Rats; Rats, Transgenic; Rats, Wistar; Recovery of Function; Stroke, Lacunar; Time Factors | 2013 |
Relationship between ouabain and asthenozoospermia.
Topics: Animals; Asthenozoospermia; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Injections, Intraperitoneal; Male; Ouabain; Rats; Rats, Sprague-Dawley; Semen; Sperm Motility; Spermatozoa; Time Factors | 2014 |
Dissociating effects of spatial learning from locomotor activity for ouabain-induced bipolar disorder-like rats.
Topics: Animals; Bipolar Disorder; Cognition; Disease Models, Animal; Male; Maze Learning; Motor Activity; Ouabain; Rats; Rats, Wistar; Space Perception; Swimming | 2014 |
The alkaloid matrine of the root of Sophora flavescens prevents arrhythmogenic effect of ouabain.
Topics: Action Potentials; Alkaloids; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Calcium Channels, L-Type; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Guinea Pigs; Matrines; Myocytes, Cardiac; Ouabain; Quinolizines; Sophora | 2014 |
The protective effect of melatonin against brain oxidative stress and hyperlocomotion in a rat model of mania induced by ouabain.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Catalase; Cerebral Cortex; Disease Models, Animal; Glutathione Peroxidase; Hippocampus; Lithium Chloride; Locomotion; Male; Melatonin; Motor Activity; Neuroprotective Agents; Ouabain; Oxidative Stress; Protein Carbonylation; Rats; Rats, Wistar; Superoxide Dismutase | 2014 |
The role of RIP3 mediated necroptosis in ouabain-induced spiral ganglion neurons injuries.
Topics: Animals; Apoptosis; Cell Death; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Imidazoles; Indoles; Neurons; Oligopeptides; Ouabain; Rats; Rats, Sprague-Dawley; Receptor-Interacting Protein Serine-Threonine Kinases; Spiral Ganglion | 2014 |
Intracerebral Administration of BDNF Protects Rat Brain Against Oxidative Stress Induced by Ouabain in an Animal Model of Mania.
Topics: Animals; Bipolar Disorder; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Hippocampus; Humans; Injections, Intraventricular; Male; Motor Activity; Neuroprotection; Ouabain; Oxidative Stress; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2015 |
Rostafuroxin protects from podocyte injury and proteinuria induced by adducin genetic variants and ouabain.
Topics: Androstanols; Animals; Antihypertensive Agents; Calmodulin-Binding Proteins; Disease Models, Animal; Female; Genetic Variation; Hypertension; Kidney; Male; Mice; Mice, Knockout; Ouabain; Podocytes; Proteinuria; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase | 2014 |
Predicting the location of missing outer hair cells using the electrical signal recorded at the round window.
Topics: Animals; Audiometry, Pure-Tone; Auditory Threshold; Cochlear Microphonic Potentials; Disease Models, Animal; Female; Gerbillinae; Hair Cells, Auditory, Outer; Hearing Loss, Noise-Induced; Lasers; Models, Biological; Ouabain; Round Window, Ear | 2014 |
Effects of ouabain on cytokine/chemokine levels in an animal model of mania.
Topics: Animals; Antidepressive Agents; Bipolar Disorder; Brain; Cytokines; Disease Models, Animal; Exploratory Behavior; Injections, Intraventricular; Male; Ouabain; Rats | 2014 |
Histone deacetylase inhibitors reverse manic-like behaviors and protect the rat brain from energetic metabolic alterations induced by ouabain.
Topics: Animals; Antimanic Agents; Behavior, Animal; Bipolar Disorder; Brain; Butyric Acid; Citric Acid Cycle; Disease Models, Animal; Energy Metabolism; Exploratory Behavior; Histone Deacetylase Inhibitors; Lithium; Male; Motor Activity; Ouabain; Rats; Rats, Wistar; Valproic Acid | 2015 |
Sodium butyrate and mood stabilizers block ouabain-induced hyperlocomotion and increase BDNF, NGF and GDNF levels in brain of Wistar rats.
Topics: Affect; Animals; Antimanic Agents; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Butyric Acid; Disease Models, Animal; Glial Cell Line-Derived Neurotrophic Factor; Hippocampus; Histamine Antagonists; Lithium Compounds; Locomotion; Male; Motor Activity; Nerve Growth Factor; Ouabain; Prefrontal Cortex; Rats; Rats, Wistar; Treatment Outcome; Valproic Acid | 2015 |
Signaling function of Na,K-ATPase induced by ouabain against LPS as an inflammation model in hippocampus.
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Hippocampus; Inflammation; Lipopolysaccharides; Male; Ouabain; Rats; Rats, Wistar; Signal Transduction; Sodium-Potassium-Exchanging ATPase | 2014 |
The effect of SCF and ouabain on small intestinal motility dysfunction induced by gastric cancer peritoneal metastasis.
Topics: Adenocarcinoma; Animals; Blotting, Western; Cardiotonic Agents; Combined Modality Therapy; Disease Models, Animal; Electrophysiology; Female; Gastrointestinal Motility; Humans; Interstitial Cells of Cajal; Male; Mice; Mice, Nude; Ouabain; Peritoneal Neoplasms; Proto-Oncogene Proteins c-kit; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium; Stem Cell Factor; Stomach Neoplasms; Tumor Cells, Cultured | 2015 |
MMP-9 inhibition facilitates amacrine cell loss after ouabain-induced retinal damage.
Topics: Amacrine Cells; Animals; Apoptosis; Cell Death; Cell Proliferation; Disease Models, Animal; Female; Ischemia; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neuroglia; Ouabain; Rats; Rats, Sprague-Dawley; Retina; Retinal Degeneration; Retinal Ganglion Cells; Retinal Vessels | 2015 |
Complex assessment of distinct cognitive impairments following ouabain injection into the rat dorsoloateral striatum.
Topics: Animals; Brain Injuries; Cognition Disorders; Disease Models, Animal; Habits; Male; Maze Learning; Neostriatum; Ouabain; Rats; Rats, Wistar | 2015 |
Chronic ouabain treatment induces Rho kinase activation.
Topics: Amides; Animals; Disease Models, Animal; Enzyme Inhibitors; Hypertension; Male; Myosin-Light-Chain Phosphatase; Ouabain; Phenylephrine; Potassium Chloride; Pyridines; Rats; Rats, Wistar; rho-Associated Kinases | 2015 |
Effects of mood stabilizers on oxidative stress-induced cell death signaling pathways in the brains of rats subjected to the ouabain-induced animal model of mania: Mood stabilizers exert protective effects against ouabain-induced activation of the cell de
Topics: Analysis of Variance; Animals; Antimanic Agents; Bipolar Disorder; Brain; Cell Death; Disease Models, Animal; Drug Interactions; Enzyme Inhibitors; Injections, Intraventricular; Male; Mitochondria; Motor Activity; Ouabain; Oxidative Stress; Rats; Rats, Wistar; Superoxides; Thiobarbituric Acid Reactive Substances | 2015 |
Ouabain Attenuates Cardiac Hypertrophy of Male Rat Offspring Exposed to Intrauterine Growth Restriction Following High-Salt Diet Challenge.
Topics: Animal Nutritional Physiological Phenomena; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Diet, Protein-Restricted; Disease Models, Animal; Female; Fetal Growth Retardation; Fibrosis; Gene Expression Regulation; Gestational Age; Infusion Pumps, Implantable; Kidney Glomerulus; Male; Maternal Nutritional Physiological Phenomena; Myocardium; Nutritional Status; Ouabain; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Ventricular Function, Left | 2015 |
Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells.
Topics: Animals; Anions; Biological Transport; Cell Membrane; Chlorides; Colforsin; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Gene Knockout Techniques; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Mice, Knockout; Organ Culture Techniques; Ouabain; Polycystic Kidney, Autosomal Dominant; Primary Cell Culture; Sodium-Potassium-Chloride Symporters; Sodium-Potassium-Exchanging ATPase | 2015 |
Short-Lived Human Umbilical Cord-Blood-Derived Neural Stem Cells Influence the Endogenous Secretome and Increase the Number of Endogenous Neural Progenitors in a Rat Model of Lacunar Stroke.
Topics: Animals; Brain; Bromodeoxyuridine; Cell Count; Cell Proliferation; Cell Survival; Disease Models, Animal; Doublecortin Domain Proteins; Fetal Blood; Humans; Male; Matrix Metalloproteinases; Microtubule-Associated Proteins; Nerve Growth Factors; Neural Stem Cells; Neurogenesis; Neuropeptides; Ouabain; Proteome; Rats, Wistar; RNA, Messenger; Stroke, Lacunar | 2016 |
Sodium butyrate has an antimanic effect and protects the brain against oxidative stress in an animal model of mania induced by ouabain.
Topics: Animals; Antimanic Agents; Antioxidants; Bipolar Disorder; Brain; Butyric Acid; Catalase; Disease Models, Animal; Hippocampus; Hyperkinesis; Male; Ouabain; Oxidative Stress; Protein Carbonylation; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2016 |
Cognitive flexibility impairment and reduced frontal cortex BDNF expression in the ouabain model of mania.
Topics: Animals; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Cognition Disorders; Discrimination, Psychological; Disease Models, Animal; Down-Regulation; Feedback, Psychological; Frontal Lobe; Male; Maze Learning; Motor Activity; Ouabain; Probability Learning; Rats, Long-Evans; Reversal Learning; RNA, Messenger | 2017 |
Endogenous cardiac steroids in animal models of mania.
Topics: Animals; Antibodies; Behavior, Animal; Bipolar Disorder; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Frontal Lobe; Mice; Ouabain; Phosphorylation | 2016 |
Contributions of Mouse and Human Hematopoietic Cells to Remodeling of the Adult Auditory Nerve After Neuron Loss.
Topics: Animals; Antigens, CD34; Cell Differentiation; Cochlear Nerve; Cord Blood Stem Cell Transplantation; Disease Models, Animal; Fetal Blood; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Mice; Ouabain; Vestibulocochlear Nerve Diseases | 2016 |
Persistent Thalamic Sound Processing Despite Profound Cochlear Denervation.
Topics: Animals; Auditory Cortex; Auditory Perception; Cochlear Diseases; Disease Models, Animal; Enzyme Inhibitors; Evoked Potentials, Auditory, Brain Stem; Geniculate Bodies; Hearing Loss, Central; Inferior Colliculi; Mice; Neuronal Plasticity; Ouabain | 2016 |
Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Disease Models, Animal; Frontal Lobe; Glycogen Synthase Kinase 3 beta; Hippocampus; Lithium Compounds; Locomotion; Male; Ouabain; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats, Wistar; Signal Transduction; Thiazoles; Urea; Valproic Acid | 2017 |
Structural and functional characteristic of a model for deep-seated lacunar infarct in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Brain Infarction; Bromodeoxyuridine; Cell Proliferation; Discrimination Learning; Disease Models, Animal; Male; Motor Activity; Nerve Tissue Proteins; Neuropsychological Tests; Ouabain; Psychomotor Performance; Rats; Rats, Wistar; Statistics, Nonparametric; Time Factors | 2008 |
Choline produces antiarrhythmic actions in animal models by cardiac M3 receptors: improvement of intracellular Ca2+ handling as a common mechanism.
Topics: Aconitine; Animals; Arrhythmias, Cardiac; Calcium; Choline; Disease Models, Animal; Female; Guinea Pigs; Male; Myocytes, Cardiac; Ouabain; Piperidines; Rats; Rats, Wistar; Receptor, Muscarinic M3 | 2008 |
Enhanced pressor response to increased CSF sodium concentration and to central ANG I in heterozygous alpha2 Na+ -K+ -ATPase knockout mice.
Topics: Angiotensin I; Animals; Blood Pressure; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Heart Rate; Hypertension; Hypothalamus; Injections, Intraventricular; Male; Mice; Mice, Knockout; Ouabain; Renin-Angiotensin System; Sodium; Sodium-Potassium-Exchanging ATPase | 2009 |
Effect of ouabain on sodium pump alpha-isoform expression in an animal model of mania.
Topics: Animals; Bipolar Disorder; Brain; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation; Injections, Intraventricular; Male; Ouabain; Protein Isoforms; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase | 2009 |
Sodium transport in the choroid plexus and salt-sensitive hypertension.
Topics: Amiloride; Animals; Biological Transport; Choroid Plexus; Disease Models, Animal; Epithelial Sodium Channel Blockers; Epithelial Sodium Channels; Hypertension; Male; Ouabain; Rats; Rats, Inbred Dahl; Rats, Wistar; RNA, Messenger; Sodium; Sodium-Potassium-Exchanging ATPase; Sodium, Dietary | 2009 |
The antiarrhythmic effect and possible ionic mechanisms of pilocarpine on animal models.
Topics: Aconitine; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Disease Models, Animal; Female; Guinea Pigs; Male; Microscopy, Confocal; Muscarinic Agonists; Muscarinic Antagonists; Myocytes, Cardiac; Ouabain; Pilocarpine; Piperidines; Rats; Rats, Wistar; Receptor, Muscarinic M3; Time Factors | 2009 |
Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin.
Topics: Animals; Bufanolides; Canrenone; Cardiomyopathies; Cardiotonic Agents; Cells, Cultured; Disease Models, Animal; Drug Interactions; Endomyocardial Fibrosis; Fibroblasts; Mineralocorticoid Receptor Antagonists; Myocardium; Nephrectomy; Ouabain; Procollagen; Proline; Rats; Renal Insufficiency; Spironolactone; Tritium; Uremia | 2009 |
Evaluation of brain creatine kinase activity in an animal model of mania induced by ouabain.
Topics: Animals; Bipolar Disorder; Corpus Striatum; Creatine Kinase, BB Form; Disease Models, Animal; Hippocampus; Male; Motor Activity; Ouabain; Prefrontal Cortex; Rats; Rats, Wistar; Time Factors | 2010 |
Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain.
Topics: Amygdala; Analysis of Variance; Animals; Antimanic Agents; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Hippocampus; Lithium Chloride; Male; Motor Activity; Ouabain; Rats; Rats, Wistar; Valproic Acid | 2010 |
Preconditioning by subinotropic doses of ouabain in the Langendorff perfused rabbit heart.
Topics: Animals; Cardiotonic Agents; Cell Death; Disease Models, Animal; Male; Myocardial Reperfusion Injury; Ouabain; Rabbits; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Species Specificity; Time Factors; Ventricular Function, Left | 2010 |
DNA damage after intracerebroventricular injection of ouabain in rats.
Topics: Animals; Bipolar Disorder; Comet Assay; Disease Models, Animal; DNA; DNA Damage; Hippocampus; Injections, Intraventricular; Male; Micronucleus Tests; Motor Activity; Ouabain; Rats; Rats, Wistar | 2010 |
Activation of Akt signaling in rat brain by intracerebroventricular injection of ouabain: a rat model for mania.
Topics: Analysis of Variance; Animals; Blotting, Western; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Forkhead Transcription Factors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Injections, Intraventricular; Male; Motor Activity; Nerve Tissue Proteins; Nitric Oxide Synthase Type III; Ouabain; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction | 2010 |
Uremia induces abnormal oxygen consumption in tubules and aggravates chronic hypoxia of the kidney via oxidative stress.
Topics: Acetophenones; Animals; Carbon; Cell Hypoxia; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Humans; Indican; Indoles; Kidney Failure, Chronic; Kidney Tubules, Proximal; Male; NADPH Oxidases; Nephrectomy; Ouabain; Oxidative Stress; Oxides; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Time Factors; Uremia | 2010 |
Lithium and valproate modulate antioxidant enzymes and prevent ouabain-induced oxidative damage in an animal model of mania.
Topics: Analysis of Variance; Animals; Antimanic Agents; Bipolar Disorder; Brain; Catalase; Disease Models, Animal; Drug Interactions; Gene Expression Regulation, Enzymologic; Injections, Intraventricular; Lithium Chloride; Male; Ouabain; Protein Carbonylation; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Valproic Acid | 2011 |
Folic acid administration prevents ouabain-induced hyperlocomotion and alterations in oxidative stress markers in the rat brain.
Topics: Animals; Antimanic Agents; Biomarkers; Bipolar Disorder; Disease Models, Animal; Folic Acid; Hippocampus; Injections, Intraventricular; Lithium Chloride; Male; Motor Activity; Ouabain; Oxidative Stress; Rats; Rats, Wistar | 2010 |
Sox2 up-regulation and glial cell proliferation following degeneration of spiral ganglion neurons in the adult mouse inner ear.
Topics: Animals; Cell Proliferation; Cochlear Nerve; Disease Models, Animal; Ear, Inner; Enzyme Inhibitors; Female; Hearing Loss, Central; Male; Mice; Mice, Inbred CBA; Nerve Degeneration; Neuroglia; Ouabain; SOXB1 Transcription Factors; Spiral Ganglion; Up-Regulation | 2011 |
The secretory response of parathyroid hormone to acute hypocalcemia in vivo is independent of parathyroid glandular sodium/potassium-ATPase activity.
Topics: Animals; Calcium; Disease Models, Animal; Egtazic Acid; Enzyme Inhibitors; Hypocalcemia; Male; Ouabain; Parathyroid Glands; Parathyroid Hormone; Potassium; Rats; Rubidium Radioisotopes; Sodium-Potassium-Exchanging ATPase; Time Factors | 2011 |
Memantine reduces mania-like symptoms in animal models.
Topics: Action Potentials; Animals; Antimanic Agents; Bipolar Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Exploratory Behavior; Hippocampus; In Vitro Techniques; Lithium Chloride; Male; Memantine; Ouabain; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Time Factors | 2011 |
The neural substrates of rapid-onset Dystonia-Parkinsonism.
Topics: Animals; Basal Ganglia; Cerebellum; Disease Models, Animal; Dystonic Disorders; Electroencephalography; Enzyme Inhibitors; Humans; Mice; Motor Activity; Neural Pathways; Neurons; Ouabain; Posture; Sodium-Potassium-Exchanging ATPase; Stress, Physiological | 2011 |
Transplantation of neural differentiated human mesenchymal stem cells into the cochlea of an auditory-neuropathy guinea pig model.
Topics: Animals; Cardiotonic Agents; Cochlea; Disease Models, Animal; Female; Guinea Pigs; Hearing Loss, Central; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Neurogenesis; Ouabain; Spiral Ganglion; Transplantation, Heterologous | 2011 |
Renovascular hypertension using a modified two-kidney, one-clip approach in mice is not dependent on the α1 or α2 Na-K-ATPase ouabain-binding site.
Topics: Animals; Binding Sites; Blood Pressure; Disease Models, Animal; Female; Hypertension, Renovascular; Kidney; Male; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Ouabain; Polyurethanes; Protein Binding; Protein Subunits; Renal Artery; Sodium-Potassium-Exchanging ATPase; Surgical Instruments | 2011 |
Hypertension from chronic central sodium chloride in mice is mediated by the ouabain-binding site on the Na,K-ATPase α₂-isoform.
Topics: Animals; Binding Sites; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brain; Cardenolides; Disease Models, Animal; Heart Rate; Hypertension; Infusions, Intraventricular; Mice; Mice, Knockout; Mice, Transgenic; Mutation; Ouabain; Saponins; Sodium Chloride; Sodium-Potassium-Exchanging ATPase; Telemetry; Time Factors | 2011 |
Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates tyrosine hydroxylase through extracellular signal-regulated kinase in rat striatum.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Injections, Intraventricular; Male; Mitogen-Activated Protein Kinase 3; Ouabain; Rats; Rats, Sprague-Dawley; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Tyrosine 3-Monooxygenase | 2011 |
A sodium channel knockin mutant (NaV1.4-R669H) mouse model of hypokalemic periodic paralysis.
Topics: Amino Acid Substitution; Animals; Disease Models, Animal; Female; Gene Knock-In Techniques; Glucose; Homozygote; Humans; Hypokalemic Periodic Paralysis; Insulin; Isometric Contraction; Male; Mice; Mice, Mutant Strains; Mutagenesis, Site-Directed; Mutant Proteins; NAV1.4 Voltage-Gated Sodium Channel; Ouabain; Phenotype; Potassium; Sodium Channels | 2011 |
Role of stromal cell-derived factor-1 expression in the injured mouse auditory nerve.
Topics: Animals; Blotting, Western; Chemokine CXCL12; Cochlear Nerve; Confidence Intervals; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Gene Expression Regulation; Hearing Loss, Sensorineural; Immunohistochemistry; Mice; Mice, Inbred CBA; Ouabain; Random Allocation; Reference Values; Vestibulocochlear Nerve Injuries | 2011 |
NADPH oxidase and PKC contribute to increased Na transport by the thick ascending limb during type 1 diabetes.
Topics: Animals; Biological Transport; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Enzyme Inhibitors; Furosemide; Loop of Henle; Male; NADPH Oxidases; Ouabain; Oxygen Consumption; Protein Kinase C-alpha; Rats; Rats, Sprague-Dawley; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Streptozocin | 2012 |
Effect of ouabain on myocardial ultrastructure and cytoskeleton during the development of ventricular hypertrophy.
Topics: Animals; Blood Pressure; Cytoskeleton; Desmin; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Hypertrophy, Left Ventricular; Male; Microscopy, Electron, Transmission; Myocardium; Ouabain; Profilins; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA, Messenger | 2013 |
Ouabain and insulin induce sodium pump endocytosis in renal epithelium.
Topics: Animals; Blotting, Western; Cells, Cultured; Disease Models, Animal; Endocytosis; Enzyme Inhibitors; Hypertension; Hypoglycemic Agents; Immunoprecipitation; Insulin; Kidney Tubules, Proximal; Male; Mice; Mice, Knockout; Ouabain; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Swine; Urothelium | 2012 |
Discovery of N-(3,5-bis(1-pyrrolidylmethyl)-4-hydroxybenzyl)-4-methoxybenzenesulfamide (sulcardine) as a novel anti-arrhythmic agent.
Topics: Aconitine; Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channels, L-Type; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Guinea Pigs; Male; Myocytes, Cardiac; Ouabain; Patch-Clamp Techniques; Potassium Channels; Rabbits; Rats; Rats, Sprague-Dawley; Sodium Channels; Sulfuric Acid Esters | 2012 |
Immunomodulatory activity of ouabain in Leishmania leishmania amazonensis-infected Swiss mice.
Topics: Animals; Disease Models, Animal; Female; Immunologic Factors; Interferon-gamma; Leishmania; Leishmaniasis; Mice; Neutrophils; Ouabain; Tumor Necrosis Factor-alpha | 2013 |
K(Ca)3.1 channel downregulation and impaired endothelium-derived hyperpolarization-type relaxation in pulmonary arteries from chronically hypoxic rats.
Topics: Animals; Chronic Disease; Disease Models, Animal; Down-Regulation; Endothelium, Vascular; Hypoxia; Intermediate-Conductance Calcium-Activated Potassium Channels; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Ouabain; Potassium Channel Blockers; Pulmonary Artery; Rats | 2013 |
Disruption of vagal efferent axon and nerve terminal function in the postischemic myocardium.
Topics: Acetylcholine; Animals; Axons; Blood Pressure; Cats; Disease Models, Animal; Electric Stimulation; Heart Rate; Heart Ventricles; Microdialysis; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Neurons, Efferent; Ouabain; Presynaptic Terminals; Vagus Nerve | 2002 |
Intracerebroventricular administration of ouabain as a model of mania in rats.
Topics: Animals; Bipolar Disorder; Disease Models, Animal; Drug Administration Routes; Drug Interactions; Enzyme Inhibitors; Injections, Intraventricular; Lithium; Locomotion; Male; Ouabain; Rats; Rats, Sprague-Dawley; Time Factors | 2003 |
Spatial learning transiently disturbed by intraventricular administration of ouabain.
Topics: Animals; Arachnoid; Cell Membrane; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Epithelial Cells; Fibrosis; Injections, Intraventricular; Male; Maze Learning; Memory Disorders; Meninges; Microscopy, Electron; Ouabain; Rats; Rats, Wistar; Reaction Time; Sodium-Potassium-Exchanging ATPase; Water-Electrolyte Balance | 2004 |
Norepinephrine increases alveolar fluid reabsorption and Na,K-ATPase activity.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amiloride; Animals; Biological Transport; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Male; Norepinephrine; Octopamine; Ouabain; Phenylephrine; Prazosin; Propranolol; Pulmonary Alveoli; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Up-Regulation; Water-Electrolyte Balance; Yohimbine | 2004 |
Oleic acid inhibits alveolar fluid reabsorption: a role in acute respiratory distress syndrome?
Topics: Animals; Biomarkers; Cell Line; Disease Models, Animal; In Vitro Techniques; Ion Transport; Male; Oleic Acid; Ouabain; Patch-Clamp Techniques; Pulmonary Alveoli; Pulmonary Edema; Rabbits; Reference Values; Respiratory Distress Syndrome; Sodium; Sodium-Potassium-Exchanging ATPase; Water-Electrolyte Balance | 2005 |
Increased cerebrospinal fluid levels of S100B protein in rat model of mania induced by ouabain.
Topics: Animals; Behavior, Animal; Bipolar Disorder; Disease Models, Animal; Enzyme Inhibitors; Exploratory Behavior; Male; Nerve Growth Factors; Ouabain; Rats; Rats, Wistar; S100 Calcium Binding Protein beta Subunit; S100 Proteins | 2004 |
Endobain E, a brain endogenous factor, is present and modulates NMDA receptor in ischemic conditions.
Topics: Animals; Brain Ischemia; Cerebral Cortex; Disease Models, Animal; Dizocilpine Maleate; Hydrogen-Ion Concentration; Intracellular Membranes; Male; Ouabain; Protein Binding; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Sodium-Potassium-Exchanging ATPase; Subcellular Fractions | 2005 |
Protein S100B release from rat brain slices during and after ischemia: comparison with lactate dehydrogenase leakage.
Topics: Animals; Brain; Brain Ischemia; Calcium; Disease Models, Animal; Energy Metabolism; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutamic Acid; L-Lactate Dehydrogenase; Male; Nerve Growth Factors; Neurons; Organ Culture Techniques; Ouabain; Oxygen; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Up-Regulation | 2005 |
Resibufogenin corrects hypertension in a rat model of human preeclampsia.
Topics: Animals; Blood Pressure; Bufanolides; Disease Models, Animal; Enzyme Inhibitors; Female; Humans; Hypertension; Isoenzymes; Molecular Structure; Ouabain; Pre-Eclampsia; Pregnancy; Rats; Sodium-Potassium-Exchanging ATPase | 2006 |
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase.
Topics: Animals; Cell Hypoxia; Disease Models, Animal; Dopamine; Energy Metabolism; Enzyme Inhibitors; Glucose; Membrane Potentials; Mice; Mice, Knockout; Neurons; Oncogene Proteins; Organ Culture Techniques; Ouabain; Parkinson Disease; Patch-Clamp Techniques; Peroxiredoxins; Protein Deglycase DJ-1; Rotenone; Sodium-Potassium-Exchanging ATPase; Substantia Nigra; Uncoupling Agents | 2006 |
Involvement of Na(+), K(+)-ATPase and endogenous digitalis-like compounds in depressive disorders.
Topics: Adult; Animals; Behavior, Animal; Bipolar Disorder; Bufanolides; Cardenolides; Depressive Disorder; Disease Models, Animal; Female; Humans; Male; Middle Aged; Mood Disorders; Ouabain; Parietal Lobe; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reference Values; Schizophrenia; Sodium-Potassium-Exchanging ATPase; Synaptosomes | 2006 |
Efficacy of olanzapine and haloperidol in an animal model of mania.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Bipolar Disorder; Disease Models, Animal; Drug Evaluation; Drug Interactions; Enzyme Inhibitors; Exploratory Behavior; Haloperidol; Male; Olanzapine; Ouabain; Rats; Rats, Sprague-Dawley | 2006 |
Interstitial K+ concentration in active muscle after myocardial infarction.
Topics: Animals; Coronary Vessels; Disease Models, Animal; Electric Stimulation; Enzyme Inhibitors; Extracellular Fluid; Ligation; Male; Microdialysis; Muscle Contraction; Muscle Fatigue; Muscle, Skeletal; Myocardial Infarction; Ouabain; Potassium; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Sodium-Potassium-Exchanging ATPase; Time Factors | 2007 |
Ouabain protects rat hearts against ischemia-reperfusion injury via pathway involving src kinase, mitoKATP, and ROS.
Topics: Adenosine Diphosphate; Animals; Cardiotonic Agents; Creatine; Disease Models, Animal; Heart Rate; Male; Mitochondria, Heart; Mitochondrial Membranes; Myocardial Reperfusion Injury; Ouabain; Oxygen Consumption; Permeability; Potassium Channels; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; src-Family Kinases | 2007 |
Increased inhibitory input to CA1 pyramidal cells alters hippocampal gamma frequency oscillations in the MK-801 model of acute psychosis.
Topics: Acute Disease; Animals; Disease Models, Animal; Dizocilpine Maleate; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Hippocampus; Inhibitory Postsynaptic Potentials; Kainic Acid; Mice; Mice, Inbred C57BL; Neural Inhibition; Organ Culture Techniques; Ouabain; Psychoses, Substance-Induced; Pyramidal Cells; Schizophrenia; Sodium-Potassium-Exchanging ATPase | 2007 |
Regulation of renal ouabain-resistant Na+-ATPase by leptin, nitric oxide, reactive oxygen species, and cyclic nucleotides: implications for obesity-associated hypertension.
Topics: Adenosine Triphosphatases; Animals; Cation Transport Proteins; Disease Models, Animal; Enzyme Inhibitors; Free Radical Scavengers; Hypertension; Kidney Tubules, Proximal; Leptin; Male; Nitric Oxide; Nucleotides, Cyclic; Obesity; Ouabain; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase | 2007 |
Enhanced survival of bone-marrow-derived pluripotent stem cells in an animal model of auditory neuropathy.
Topics: Animals; Cell Survival; Cochlea; Cochlear Nerve; Disease Models, Animal; Enzyme Inhibitors; Factor Analysis, Statistical; Female; Gerbillinae; Hearing Loss, Sensorineural; Injections; Male; Mesenchymal Stem Cell Transplantation; Mice; Microscopy, Confocal; Ouabain; Peripheral Nervous System Diseases; Pluripotent Stem Cells; Spiral Ganglion; Transplantation, Heterologous; Tympanic Membrane | 2007 |
Antinociceptive synergistic interaction between clonidine and ouabain on thermal nociceptive tests in the rat.
Topics: Analgesics; Animals; Behavior, Animal; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Hyperalgesia; Male; Ouabain; Pain Measurement; Rats; Rats, Sprague-Dawley; Reaction Time; Time Factors | 2007 |
Altered Na+/Ca2+-exchanger activity due to downregulation of Na+/K+-ATPase alpha2-isoform in heart failure.
Topics: Animals; Calcium Signaling; Cytoskeleton; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Heart Failure; Immunohistochemistry; Male; Membrane Potentials; Microscopy, Confocal; Microscopy, Electron; Muscle Contraction; Myocardial Infarction; Myocytes, Cardiac; Ouabain; Patch-Clamp Techniques; Rats; Rats, Wistar; Sodium; Sodium-Calcium Exchanger; Sodium-Potassium-Exchanging ATPase | 2008 |
Experimental metastasis assays in the chick embryo.
Topics: Animals; Chick Embryo; Disease Models, Animal; Fluorescent Dyes; Humans; In Vitro Techniques; Liver Neoplasms, Experimental; Methods; Mice; Microscopy, Video; Nanospheres; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Ouabain; Species Specificity; Transplantation, Heterologous; Tumor Cells, Cultured | 2004 |
Properties of thiamine transport in isolated perfused hearts of chronically alcoholic guinea pigs.
Topics: Alcoholism; Animals; Biological Transport, Active; Carbon Radioisotopes; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Disease Models, Animal; Enzyme Inhibitors; Female; Guinea Pigs; Kinetics; Male; Myocardium; Ouabain; Oxidative Phosphorylation; Perfusion; Radioisotope Dilution Technique; Sodium; Sodium-Potassium-Exchanging ATPase; Thiamine; Uncoupling Agents; Vitamin B Complex | 2008 |
Src activation generates reactive oxygen species and impairs metabolism-secretion coupling in diabetic Goto-Kakizaki and ouabain-treated rat pancreatic islets.
Topics: Adenosine Triphosphate; Animals; Cells, Cultured; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Free Radical Scavengers; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mitochondria; Mitochondrial Membranes; Ouabain; Phosphorylation; Rats; Rats, Mutant Strains; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Sodium-Potassium-Exchanging ATPase; src-Family Kinases | 2008 |
Transplantation of mouse embryonic stem cells into the cochlea of an auditory-neuropathy animal model: effects of timing after injury.
Topics: Animals; Cell Death; Cell Differentiation; Cells, Cultured; Cochlea; Disease Models, Animal; Embryonic Stem Cells; Endolymph; Enzyme Inhibitors; Female; Gerbillinae; Graft Survival; Hearing Loss, Sensorineural; Male; Mice; Neovascularization, Physiologic; Neuroglia; Neurons, Afferent; Ouabain; Perilymph; Spiral Ganglion; Stem Cell Transplantation | 2008 |
ACTH-induced hypertension is dependent on the ouabain-binding site of the alpha2-Na+-K+-ATPase subunit.
Topics: Adrenergic beta-Agonists; Adrenocorticotropic Hormone; Aldosterone; Animals; Binding Sites; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cerebrovascular Circulation; Corticosterone; Disease Models, Animal; Drug Resistance; Enzyme Inhibitors; Genotype; Hypertension; Mice; Mice, Transgenic; Muscle, Smooth, Vascular; Mutation; Myocardium; Ouabain; Phenotype; Regional Blood Flow; Renal Circulation; Sodium-Potassium-Exchanging ATPase; Splanchnic Circulation; Telemetry; Time Factors; Vascular Resistance; Vasoconstrictor Agents; Ventricular Function, Left | 2008 |
Effect of hyperphenylalaninemia on Na+ + K+-ATPase in rat brain.
Topics: Adenosine Triphosphatases; Animals; Brain; Ca(2+) Mg(2+)-ATPase; Disease Models, Animal; Enzyme Activation; Fenclonine; Kinetics; Mitochondria; Ouabain; Phenylalanine; Rats; Rats, Inbred Strains; Sodium-Potassium-Exchanging ATPase; Synaptosomes | 1981 |
The role of a humoral sodium-potassium pump inhibitor in low-renin hypertension.
Topics: Animals; Biological Transport, Active; Disease Models, Animal; Dogs; Humans; Hypertension; Muscle, Smooth, Vascular; Ouabain; Potassium; Rats; Renin; Rubidium; Sodium | 1983 |
Antiarrhythmic effect of disulfiram in various cardiotoxic models.
Topics: Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Disulfiram; Heart Diseases; Male; Myocardial Contraction; Ouabain; Quinidine; Rabbits; Rats; Rats, Inbred Strains | 1983 |
Susceptibility of infarcted canine hearts to digitalis-toxic ventricular tachycardia.
Topics: Animals; Digitalis Glycosides; Disease Models, Animal; Disease Susceptibility; Dogs; Dose-Response Relationship, Drug; Electrophysiology; Heart Septum; Heart Ventricles; Myocardial Infarction; Ouabain; Tachycardia | 1983 |
Genetic markers in spontaneously hypertensive rats.
Topics: Animals; Blood Proteins; Cell Membrane Permeability; Clemastine; Disease Models, Animal; Erythrocyte Membrane; Genetic Markers; Hypertension; Ouabain; Rats; Rats, Inbred Strains; Sodium; Species Specificity | 1981 |
Myocardial effects and pharmacokinetics of digoxin and ouabain in protein-deficient guinea pigs.
Topics: Animals; Digoxin; Disease Models, Animal; Guinea Pigs; In Vitro Techniques; Kinetics; Male; Myocardial Contraction; Myocardium; Ouabain; Protein Deficiency; Stimulation, Chemical | 1980 |
Antiarrhythmic effects of bisaramil on triggered arrhythmias produced by intracoronary injection of digitalis and adrenaline in the dog.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bridged Bicyclo Compounds, Heterocyclic; Chlorobenzenes; Digitalis Glycosides; Disease Models, Animal; Disopyramide; Dogs; Epinephrine; Female; Flecainide; Injections, Intra-Arterial; Lidocaine; Male; Ouabain; Verapamil | 1995 |
Effects of a new forskolin derivative, NKH477, on canine ventricular arrhythmia models.
Topics: Analysis of Variance; Animals; Arrhythmias, Cardiac; Blood Pressure; Colforsin; Disease Models, Animal; Dogs; Electrocardiography; Epinephrine; Female; Heart Rate; Injections, Intravenous; Male; Myocardial Contraction; Ouabain; Vasodilator Agents | 1993 |
Effects of diazoxide on norepinephrine-induced vasocontraction and ischemic myocardium in rats.
Topics: Analysis of Variance; Animals; Aorta, Thoracic; Calcium; Diazoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorometry; Fura-2; Glyburide; In Vitro Techniques; Lactates; Lactic Acid; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Myocardial Ischemia; Norepinephrine; Ouabain; Rats; Rats, Wistar; Vasoconstriction; Vasodilator Agents | 1994 |
Anti-arrhythmic profile of a garlic dialysate assayed in dogs and isolated atrial preparations.
Topics: Aconitine; Animals; Arrhythmias, Cardiac; Dialysis; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Electrocardiography; Female; Garlic; Heart Atria; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Ouabain; Plant Extracts; Plants, Medicinal; Propranolol; Rats; Refractory Period, Electrophysiological; Tachycardia | 1994 |
Effects of OPC-18790, a new positive inotropic agent, on canine ventricular arrhythmias.
Topics: Animals; Blood Pressure; Cardiotonic Agents; Coronary Circulation; Disease Models, Animal; Dogs; Epinephrine; Female; Heart Rate; Male; Myocardial Contraction; Myocardial Ischemia; Ouabain; Quinolones; Tachycardia, Ventricular; Vasodilation; Ventricular Fibrillation | 1993 |
Increased cytosolic sodium and reduced Na,K-ATPase activity in transgenic rats.
Topics: Animals; Animals, Genetically Modified; Cells, Cultured; Cytosol; Disease Models, Animal; Hypertension; Kinetics; Lymphocytes; Mice; Ouabain; Rats; Rats, Sprague-Dawley; Renin; Sodium; Sodium-Potassium-Exchanging ATPase; Spectrometry, Fluorescence; Time Factors | 1994 |
An animal model for mania: preliminary results.
Topics: Animals; Bipolar Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Locomotion; Male; Ouabain; Rats; Rats, Sprague-Dawley; Time Factors | 1995 |
Efficacy of the class III antiarrhythmic agent azimilide in rodent models of ventricular arrhythmia.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Chloroform; Constriction; Coronary Vessels; Disease Models, Animal; Dose-Response Relationship, Drug; Guinea Pigs; Heart Rate; Hydantoins; Imidazoles; Imidazolidines; Male; Mice; Ouabain; Piperazines; Propranolol; Rats; Rats, Sprague-Dawley | 1996 |
Effect of insulin on norepinephrine overflow at peripheral sympathetic nerve endings in young spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Buffers; Cocaine; Disease Models, Animal; Dopamine Uptake Inhibitors; Electric Stimulation; Enzyme Inhibitors; Hypertension; Insulin; Male; Nerve Endings; Norepinephrine; Ouabain; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium Chloride, Dietary; Sodium-Potassium-Exchanging ATPase; Sympathetic Nervous System; Yohimbine | 1996 |
Ischemia-induced alteration of myocardial Na(+)-K(+)-ATPase activity and ouabain binding sites in hypercholesterolemic rabbits.
Topics: Animals; Binding Sites; Ca(2+) Mg(2+)-ATPase; Disease Models, Animal; Hypercholesterolemia; Intracellular Fluid; Male; Myocardial Ischemia; Myocardium; Ouabain; Potassium; Rabbits; Sodium; Sodium-Potassium-Exchanging ATPase | 1996 |
Induction of tolerance in rat cortical neurons: hypoxic preconditioning.
Topics: Animals; Brain Ischemia; Cell Hypoxia; Cells, Cultured; Disease Models, Animal; DNA Fragmentation; Electrophoresis, Agar Gel; Female; Glucose; Ischemic Preconditioning; L-Lactate Dehydrogenase; Microscopy, Phase-Contrast; Neurons; Ouabain; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase | 1997 |
Regulation of Na+, K(+)-ATPase in the rat outer medullary collecting duct during potassium depletion.
Topics: Animals; Base Sequence; Culture Techniques; Disease Models, Animal; Enzyme Inhibitors; Fluorescent Antibody Technique, Indirect; H(+)-K(+)-Exchanging ATPase; Kidney Medulla; Kidney Tubules, Collecting; Male; Molecular Sequence Data; Ouabain; Polymerase Chain Reaction; Potassium Deficiency; Potassium, Dietary; Rats; Rats, Sprague-Dawley; Reference Values; Sodium-Potassium-Exchanging ATPase; Up-Regulation | 1998 |
Comparative study of the effects of ouabain and digoxin on blood pressure of rats.
Topics: Animals; Blood Pressure; Cardiotonic Agents; Digoxin; Disease Models, Animal; Hypertension; Male; Ouabain; Random Allocation; Rats; Rats, Sprague-Dawley | 1997 |
The effect of ouabain on water diffusion in the rat hippocampal slice measured by high resolution NMR imaging.
Topics: Animals; Body Water; Brain Ischemia; Diffusion; Disease Models, Animal; Enzyme Inhibitors; Hippocampus; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Male; Ouabain; Rats; Rats, Sprague-Dawley | 1999 |
Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
Topics: Animals; Disease Models, Animal; Dogs; Hypertension, Renal; Kidney; Kidney Cortex; Kidney Medulla; Magnesium; Male; Ouabain; Sodium-Potassium-Exchanging ATPase; Time Factors | 1999 |
Inhibition of Na,K-ATPase by external electrical cardioversion in a sheep model of atrial fibrillation.
Topics: Animals; Atrial Fibrillation; Atrial Natriuretic Factor; Biomarkers; Blotting, Western; Cardiac Pacing, Artificial; Disease Models, Animal; Electric Countershock; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Fatty Acids; Ion Transport; Membrane Fluidity; Microsomes; Myocardium; Ouabain; Sarcolemma; Sheep; Sodium-Potassium-Exchanging ATPase | 2000 |
Open field is more sensitive than automated activity monitor in documenting ouabain-induced hyperlocomotion in the development of an animal model for bipolar illness.
Topics: Animals; Bipolar Disorder; Disease Models, Animal; Enzyme Inhibitors; Exploratory Behavior; Male; Movement Disorders; Ouabain; Rats; Rats, Sprague-Dawley | 2000 |
Phenotypical features of long Q-T syndrome in transgenic mice expressing human Na-K-ATPase alpha(3)-isoform in hearts.
Topics: Animals; Cardiac Pacing, Artificial; Cells, Cultured; Disease Models, Animal; Electrocardiography; Enzyme Inhibitors; Humans; In Vitro Techniques; Isoenzymes; Linear Models; Long QT Syndrome; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; Ouabain; Phenotype; Sodium-Potassium-Exchanging ATPase; Tachycardia, Ventricular | 2000 |
Molecular, genetic and physiological characterisation of dystrobrevin-like (dyb-1) mutants of Caenorhabditis elegans.
Topics: Acetylcholine; Acetylcholinesterase; Amino Acid Sequence; Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Cloning, Molecular; Disease Models, Animal; Electrophysiology; Fluoresceins; Gene Expression; Helminth Proteins; Molecular Sequence Data; Muscle Proteins; Muscular Diseases; Mutation; Myogenic Regulatory Factors; Nerve Tissue Proteins; Neuropeptides; Nuclear Proteins; Ouabain; Phenotype; Sequence Homology, Amino Acid; Transcription Factors | 2001 |
Defective activity and isoform of the Na,K-ATPase in the dilated cardiomyopathic hamster.
Topics: Animals; Body Weight; Cardiomyopathy, Dilated; Cell Fractionation; Cricetinae; Digitoxigenin; Disease Models, Animal; Enzyme Inhibitors; Heart; Humans; Immunoblotting; Isoenzymes; Male; Mesocricetus; Microsomes; Myocardium; Organ Size; Ouabain; Sodium-Potassium-Exchanging ATPase | 2001 |
Synaptic plasticity in sympathetic ganglia from acquired and inherited forms of ouabain-dependent hypertension.
Topics: Action Potentials; Animals; Blood Pressure; Digoxin; Disease Models, Animal; Electrophysiology; Humans; Hypertension; In Vitro Techniques; Long-Term Potentiation; Male; Neuronal Plasticity; Ouabain; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Superior Cervical Ganglion | 2001 |
Effects of small doses of ouabain on the arterial blood pressure of anesthetized hypertensive and normotensive rats.
Topics: Analysis of Variance; Animals; Blood Pressure; Cardiotonic Agents; Desoxycorticosterone; Disease Models, Animal; Hypertension; Hypertension, Renovascular; Male; Ouabain; Phenylephrine; Rats; Rats, Wistar; Vasoconstriction | 2001 |
Exogenous anandamide protects rat brain against acute neuronal injury in vivo.
Topics: Animals; Animals, Newborn; Arachidonic Acids; Blotting, Western; Brain; Brain Edema; Brain Injuries; Cannabinoid Receptor Modulators; Cannabinoids; Disease Models, Animal; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Glycerides; Longitudinal Studies; Magnetic Resonance Imaging; Microinjections; Neurons; Ouabain; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 2001 |
Examination of stomach wall Mg2+-Na+-K+-dependent ATPase, ATP, and ADP in pylorus-ligated rats.
Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Depression, Chemical; Disease Models, Animal; Female; Gastric Acidity Determination; Gastric Juice; Gastric Mucosa; Ligation; Magnesium; Male; Ouabain; Potassium; Pylorus; Rats; Sodium; Stomach; Stomach Ulcer | 1976 |
Antiarrhythmic effect of hypertonic sodium bicarbonate and sodium chloride in ouabain-induced arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Bicarbonates; Cats; Disease Models, Animal; Electrocardiography; Mannitol; Osmolar Concentration; Ouabain; Perphenazine; Promethazine; Saline Solution, Hypertonic; Sodium; Sodium Chloride; Tachycardia | 1976 |
[Experimental status spongiosus in the brain tissue of chick embryos].
Topics: Animals; Cerebral Cortex; Chick Embryo; Creutzfeldt-Jakob Syndrome; Disease Models, Animal; Electroencephalography; Evoked Potentials; Humans; Injections, Spinal; Ouabain | 1975 |
Effects of ouabain and norepinephrine on the mechanical performance of the normal and failing heart of the myopathic hamster.
Topics: Animals; Blood Pressure; Cricetinae; Disease Models, Animal; Heart; Heart Failure; Male; Myocardium; Norepinephrine; Ouabain; Oxygen Consumption | 1976 |
Autonomic nervous system dysfunction alters drug effects: implications for testing drugs for the treatment of heart failure.
Topics: Animals; Autonomic Nervous System; Cardiovascular Agents; Disease Models, Animal; Enalapril; Heart Failure; Heart Rate; Milrinone; Myocardial Contraction; Nitroprusside; Ouabain; Propranolol; Pyridones; Rabbits; Vagotomy; Vasodilator Agents | 1992 |
Controlling cardiac chaos.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium; Disease Models, Animal; Electric Stimulation Therapy; Electrophysiology; Epinephrine; Heart; Heart Rate; Ouabain; Rabbits | 1992 |
Ouabain-induced changes of calcium and potassium in slices of hippocampus of the rat: comparison to hypoxia and effect of R 56865.
Topics: Animals; Benzothiazoles; Brain Ischemia; Calcium; Disease Models, Animal; Hippocampus; Hypoxia, Brain; In Vitro Techniques; Male; Ouabain; Piperidines; Potassium; Rats; Rats, Inbred Strains; Thiazoles | 1992 |
Aldosterone reduces baroreceptor discharge in the dog.
Topics: Aldosterone; Animals; Blood Pressure; Disease Models, Animal; Dogs; Endothelium, Vascular; Female; Heart Failure; Male; Ouabain; Pressoreceptors; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone | 1992 |
Effects of a new antiarrhythmic drug TYB-3823 on canine ventricular arrhythmia models.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Epinephrine; Female; Guanidines; Male; Ouabain; Ventricular Function | 1991 |
Modulation of baroreflex and baroreceptor function in experimental heart failure.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dogs; Electrophysiology; Heart Failure; Heart Rate; Nitroglycerin; Ouabain; Phenylephrine; Pressoreceptors; Reflex, Abnormal; Vagotomy | 1991 |
Isolated paced guinea pig left atrium: a new ouabain-induced arrhythmia model.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Function, Left; Clonidine; Disease Models, Animal; Drug Evaluation; Female; Guinea Pigs; In Vitro Techniques; Lidocaine; Male; Ouabain; Propranolol; Reproducibility of Results | 1991 |
Protective effects of dazmegrel on the PAF potential of ouabain-induced cardiac arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Disease Models, Animal; Drug Synergism; Female; Guinea Pigs; Imidazoles; Lysine; Ouabain; Platelet Activating Factor; Thromboxane-A Synthase | 1991 |
["Push-pull" perfusion technic, a new approach applied to the study of transdentinal fluid].
Topics: Age Factors; Animals; Colchicine; Dentin; Dentin Permeability; Dentin Sensitivity; Disease Models, Animal; Extracellular Space; Ouabain; Perfusion; Rats | 1990 |
Antiarrhythmic effects of the class 1c antiarrhythmic drug, flecainide, on canine ventricular arrhythmia models.
Topics: Animals; Arrhythmias, Cardiac; Coronary Vessels; Disease Models, Animal; Dogs; Epinephrine; Flecainide; Ligation; Ouabain | 1989 |
Astrocytic swelling in traumatic-hypoxic brain injury. Beneficial effects of an inhibitor of anion exchange transport and glutamate uptake in glial cells.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; Animals; Astrocytes; Biological Transport; Brain; Brain Injuries; Cats; Cells, Cultured; Chlorides; Disease Models, Animal; Fluorenes; Glutamates; Glutamic Acid; Hypoxia, Brain; Ouabain; Potassium; Rats | 1989 |
Mechanical and electrical properties of cardiomyopathic hearts of Syrian hamsters.
Topics: Action Potentials; Animals; Body Weight; Cardiomyopathies; Cricetinae; Disease Models, Animal; Electrolytes; Heart; Heart Rate; Membrane Potentials; Mesocricetus; Myocardial Contraction; Organ Size; Ouabain; Reference Values | 1989 |
Effects of dantrolene sodium in rodent models of cardiac arrhythmia.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Dantrolene; Disease Models, Animal; Electric Stimulation; Electrophysiology; Guinea Pigs; In Vitro Techniques; Male; Mice; Ouabain; Rats; Rats, Inbred Strains; Ventricular Fibrillation | 1989 |
Electrophysiologic, antiarrhythmic and cardiovascular actions of UM301, a quaternary ammonium compound.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Node; Coronary Disease; Disease Models, Animal; Dogs; Heart Atria; Heart Ventricles; Hemodynamics; Male; Ouabain; Propanolamines; Quaternary Ammonium Compounds; Sinoatrial Node | 1986 |
Different cation transport inhibitor in benign and malignant experimental renal hypertension.
Topics: Animals; Biological Transport; Cations; Depression, Chemical; Disease Models, Animal; Furosemide; Hypertension, Renal; Male; Muscle, Smooth, Vascular; Ouabain; Radioisotopes; Rats; Rats, Inbred F344; Rubidium | 1986 |
Properties of cortical seizure potential fields.
Topics: Action Potentials; Animals; Cerebral Cortex; Computers; Disease Models, Animal; Electric Stimulation; Electroencephalography; Ouabain; Rabbits; Seizures | 1970 |
[A method for the production of digitalic arrhythmia in dogs].
Topics: Animals; Arrhythmias, Cardiac; Body Weight; Cardiac Complexes, Premature; Disease Models, Animal; Dogs; Electrocardiography; Heart Ventricles; Methods; Ouabain; Tachycardia; Time Factors | 1971 |
[Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395)].
Topics: Adrenergic beta-Antagonists; Amino Alcohols; Animals; Anti-Arrhythmia Agents; Anura; Arrhythmias, Cardiac; Benzopyrans; Disease Models, Animal; Dogs; Epinephrine; Guinea Pigs; Ligation; Ouabain; Propanolamines; Propranolol; Propylamines; Sciatic Nerve; Sulfides; Thiophenes | 1973 |
A method to determine the efficiency of anti-epileptic drugs on experimental cortical seizures.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Electroencephalography; Ouabain; Rabbits; Seizures | 1970 |
Brain synapses. An in vitro model for the study of seizures.
Topics: Adenosine Triphosphatases; Animals; Biological Transport; Brain; Disease Models, Animal; Electroencephalography; Electrophysiology; Electroshock; Epilepsy; Humans; Membrane Potentials; Ouabain; Phenytoin; Potassium; Rats; Rats, Inbred Strains; Sodium; Synapses; Synaptic Membranes; Synaptic Vesicles; Synaptosomes | 1972 |
Effects of oxyfedrine and ouabain on the heart-lung preparation of the dog.
Topics: Amino Alcohols; Animals; Arrhythmias, Cardiac; Cardiac Output; Disease Models, Animal; Dogs; Female; Heart; Heart Failure; In Vitro Techniques; Male; Ouabain; Pentobarbital; Phenethylamines; Propiophenones; Propranolol; Reserpine; Ventricular Fibrillation | 1973 |
Zinc, taurine, and epilepsy.
Topics: Adenosine Triphosphatases; Adult; Aminobutyrates; Animals; Behavior, Animal; Brain; Cerebral Cortex; Copper; Disease Models, Animal; Epilepsy; Hippocampus; Humans; Hypothalamus; Manganese; Medulla Oblongata; Mitochondria; Myelin Sheath; Ouabain; Potassium; Rats; Sodium; Synaptosomes; Taurine; Tritium; Zinc | 1974 |
Catecholamine, protein, and RNA content in advanced congestive heart failure in the Syrian hamster.
Topics: Animals; Cardiomegaly; Cricetinae; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Heart; Heart Failure; Heart Rate; Male; Muscle Proteins; Myocardial Contraction; Norepinephrine; Organ Size; Ouabain; RNA | 1972 |
[Neurophysiologic models of epilepsy].
Topics: Action Potentials; Animals; Brain; Cats; Cell Membrane Permeability; Cold Temperature; Cortical Spreading Depression; Disease Models, Animal; Electric Stimulation; Electroencephalography; Electrophysiology; Epilepsy; Membrane Potentials; Metabolic Diseases; Models, Biological; Neurons; Neurons, Afferent; Neurophysiology; Ouabain; Penicillins; Pentylenetetrazole; Potassium; Receptors, Neurotransmitter; Sodium; Strychnine; Synaptic Membranes; Synaptic Vesicles | 1972 |
Myotonia induced by monocarboxylic aromatic acids. A possible mechanism.
Topics: 2,4-Dichlorophenoxyacetic Acid; Adenosine Triphosphatases; Animals; Benzoates; Carboxylic Acids; Cell Membrane Permeability; Disease Models, Animal; Magnesium; Microsomes; Muscles; Myotonia; Nitrophenols; Ouabain; Phosphoric Monoester Hydrolases; Potassium; Rats; Sarcolemma; Sodium | 1973 |
Congenitally impaired hormone sensitivity of the adipose tissue of spontaneously diabetic mice, KK. Validity of thrifty genotype in KK mice.
Topics: Adipose Tissue; Animals; Concanavalin A; Cyclic AMP; Diabetes Mellitus; Disease Models, Animal; Epinephrine; Fasting; Fatty Acids, Nonesterified; Glucose; Insulin; Lipid Metabolism; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Ouabain; Potassium; Theophylline | 1974 |
Anti-arrhythmic effects of lidocaine metabolites.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Drug Evaluation; Ethylamines; Guinea Pigs; Heart Atria; Lidocaine; Male; Methylamines; Ouabain | 1974 |
The effect of reserpine and d,l-propranolol on digitalis-induced arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Cardanolides; Disease Models, Animal; Dogs; Heart Arrest; Lethal Dose 50; Male; Ouabain; Propranolol; Reserpine; Ventricular Fibrillation | 1973 |
The action of cardiac glycosides in cerebral edema.
Topics: Animals; Brain; Brain Chemistry; Brain Edema; Cardiac Glycosides; Coma; Dinitrophenols; Disease Models, Animal; Hemiplegia; Humans; Male; Middle Aged; Ouabain; Rats; Seizures; Sodium; Water | 1973 |
Modification of experimental myocardial infarct size by cardiac drugs.
Topics: Animals; Blood Pressure; Cardiac Catheterization; Cardiac Volume; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Dogs; Heart; Heart Rate; Isoproterenol; Methoxamine; Myocardial Infarction; Myocardium; Norepinephrine; Ouabain; Oxygen Consumption | 1974 |
[Effect of Cardilan infusion on the arrhythmic and lethal dose of g-strophantin in a model of experimental isoprenaline necrosis].
Topics: Animals; Arrhythmias, Cardiac; Asparagine; Disease Models, Animal; Heart; Heart Rate; Injections, Intravenous; Isoproterenol; Necrosis; Ouabain; Rabbits | 1972 |
Observations on models used for the evaluation of antiarrhythmic drugs.
Topics: Alkaloids; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Atropine; Benzazepines; Bretylium Compounds; Chlorpheniramine; Diazepam; Disease Models, Animal; Dogs; Drug Antagonism; Guinea Pigs; Imipramine; Ketones; Lidocaine; Male; Meperidine; Mephentermine; Ouabain; Phentolamine; Phenytoin; Procainamide; Promazine; Promethazine; Propranolol; Quinidine | 1971 |
A comparison of the effects of bretylium, lignocaine and propranolol on experimental cardiac arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Bretylium Compounds; Disease Models, Animal; Dogs; Epinephrine; Lidocaine; Ouabain; Propranolol | 1969 |
Enzyme studies in the dystrophic mouse.
Topics: Animals; Biological Transport; Cell Membrane; Creatine Kinase; Depression, Chemical; Disease Models, Animal; Female; Fructose-Bisphosphate Aldolase; Hexokinase; Histocytochemistry; Male; Mice; Muscles; Muscular Dystrophy, Animal; Ouabain; Proteins; Rodent Diseases; Statistics as Topic; Stimulation, Chemical | 1969 |
The effect of detergents on experimental digitalis--induced arrhythmia.
Topics: Animals; Arrhythmias, Cardiac; Biological Transport; Cell Membrane Permeability; Detergents; Digitalis Glycosides; Disease Models, Animal; Dogs; Electrocardiography; Erythrocytes; Ouabain; Potassium; Sodium; Surface-Active Agents; Tachycardia | 1970 |